Determination of the minimum inhibitory concentration ofCryptococcus neoformansandCryptococcus gattiiagainst fluconazole by flow cytometry

Correlation of antifungal susceptibility and molecular type within theCryptococcus neoformans/C. gattiispecies complex

(2012) Luciana Trilles et al.   MEDICAL MYCOLOGY

Clonality and α-a Recombination in the Australian Cryptococcus gattii VGII Population - An Emerging Outbreak in Australia

(2011) Fabian Carriconde et al.   PLoS One

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

(2010) John R. Perfect et al.   CLINICAL INFECTIOUS DISEASES

Global VGIIa isolates are of comparable virulence to the major fatal Cryptococcus gattii Vancouver Island outbreak genotype

(2010) P. Ngamskulrungroj et al.   CLINICAL MICROBIOLOGY AND INFECTION

Cerebrospinal Fluid HIV-1 Viral Load During Treatment of Cryptococcal Meningitis

(2010) Annemarie E Brouwer et al.   JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES

Primeira descrição da caracterização fenotípica e susceptibilidade in vitro a drogas de leveduras do gênero Cryptococcus spp isoladas de pacientes HIV positivos e negativos, Estado de Mato Grosso

(2010) Olivia Cometti Favalessa et al.   Revista da Sociedade Brasileira de Medicina Tropical

Central nervous system involvement in cryptococcal infection in individuals after solid organ transplantation or with AIDS

(2009) J.A. Davis et al.   Transplant Infectious Disease

Regional pattern of the molecular types of Cryptococcus neoformans and Cryptococcus gattii in Brazil

(2008) Luciana Trilles et al.   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Pulmonary Cryptococcosis

(2008) Joseph Jarvis et al.   SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE